Stocktwits on MSN
HIMS stock plunges 10% after hours: FDA chief warns of 'swift action' on copycat drugs after Novo semaglutide knockoff launch
The drop followed a same-day launch of a compounded semaglutide pill that drew FDA warnings and a legal pushback from Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results